While it has been broadly assumed that patients prefer tele-MOUD to in-person treatment, there has been minimal research in this area. Researchers at RAND Corporation wanted to fill this gap in knowledge. With a grant from the National Institute of Drug Abuse, RAND launched the first-ever study in 2021 to explore different aspects of the patient’s perspective comparing in-person to tele-MOUD treatment. As part of this study, RAND researchers conducted 20 interviews with Bicycle Health patients between March and May 2021.
About the author
Bicycle Health
Bicycle Health is the leading telehealth provider of medications for opioid use disorder (MOUD) in the United States, offering an evidence-based clinical care model that includes FDA-approved Medications for Addiction Treatment (MAT), access to a highly-trained team of medical experts, therapy, a customized treatment plan, and peer support groups. Bicycle Health’s mission is to address the country’s number one public health crisis by helping to reduce stigmas associated with opioid addiction and providing access to affordable, convenient, and confidential tele-MOUD treatment for individuals in need. The company’s “whole person” approach to treatment encourages patients to focus on their life passions and goals, which has been shown to play a vital role in recovery.
